Bi­par­ti­san bill seeks to curb drug short­ages with more in­fo to FDA on spikes in de­mand

A new bi­par­ti­san bill seeks to lim­it drug short­ages by stay­ing ahead of new de­mand in­creas­es.

Reps. Sara Ja­cobs (D-CA) and Cory Mills (R-FL) late last week in­tro­duced the Drug Short­age Pre­ven­tion Act to re­quire man­u­fac­tur­ers to no­ti­fy the FDA if they have ex­pe­ri­enced six straight weeks of in­creased prod­uct de­mand, with an aim to boost the FDA’s abil­i­ty to pre­dict and re­spond to drug short­ages.

“The Drug Short­age Pre­ven­tion Act will help lessen par­ents’ wor­ries by cre­at­ing more trans­paren­cy of the de­mand for med­ica­tion and min­i­miz­ing drug short­ages,” Ja­cobs said in a re­lease.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER